The role of the interleukin-6/gp130 signaling pathway in bone metabolism (Q36617113)

15 August 2017

1 reference

title

The role of the interleukin-6/gp130 signaling pathway in bone metabolism (English)

1 reference

15 August 2017

Xin-Hua Liu

1

1 reference

15 August 2017

Alexander Kirschenbaum

series ordinal

2

1 reference

15 August 2017

Shen Yao

series ordinal

3

1 reference

15 August 2017

Alice C Levine

series ordinal

4

1 reference

15 August 2017

language of work or name

1 reference

1 January 2006

1 reference

15 August 2017

Vitamins and Hormones

1 reference

15 August 2017

74

1 reference

15 August 2017

341-355

1 reference

Advances in the osteoblast lineage

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Clinical review 165: Markers of bone remodeling in metastatic bone disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Differential stimulation by PGE(2) and calcemic hormones of IL-6 in stromal/osteoblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

gp130 Cytokine family and bone cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Osteoclasts are not the major source of interleukin-6 in mouse parietal bones

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Interleukin-6 inhibits bone formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Increased osteoclast development after estrogen loss: mediation by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

IL-6 signal transduction and its physiological roles: the signal orchestration model

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Interleukin-6 synthesis induced by prostaglandin E2: cross-talk regulation by protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Multiple myeloma: evolving genetic events and host interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Regulation of osteoblast proliferation by leukemia inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Developmental abnormalities in mice transgenic for bovine oncostatin M.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

The role of IL-6 type cytokines and their receptors in bone.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Interleukins in the control of osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Growth hormone and bone

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Interleukin-6 modulates trabecular and endochondral bone turnover in the nude mouse by stimulating osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Involvement of interleukin-6 and prostaglandin E2 in periarticular osteoporosis of postmenopausal women with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Gp130 and the interleukin-6 family of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Flow cytometrical determination of interleukin 1beta, interleukin 6 and tumour necrosis factor alpha in monocytes of rheumatoid arthritis patients; relation with parameters of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2806%2974014-6

7 January 2021

10.1016/S0083-6729(06)74014-6

Identifiers

DOI

1 reference

15 August 2017

1 reference